Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design.

Juan Sanchis,Albert Ariza-Solé,Emad Abu-Assi,Oriol Alegre, Fernando Alfonso,José Antonio Barrabés,José Antonio Baz,Antonio Carol,Pablo Díez Villanueva,Bruno García Del Blanco,Jaime Elízaga,Eduard Fernandez, Abel García Del Egido, Joan García Picard,Iván Gómez Blázquez,Joan Antoni Gómez Hospital,Rosana Hernández-Antolín,Cinta Llibre, Francisco Marín,David Martí Sánchez,Roberto Martín, Manuel Martínez Sellés, Gema Miñana,María José Morales Gallardo, Julio Núñez,Armando Pérez de Prado,Eduardo Pinar,Marcelo Sanmartín, Alessandro Sionis,Adolfo Villa,Jaume Marrugat,Héctor Bueno

Revista Española de Cardiología (English Edition)（2019）

Cited 27|Views16

No score

Abstract

We hypothesize that the invasive strategy will improve outcomes in frail elderly patients with NSTEMI. If this is confirmed, frailty status should not dissuade physicians from implementing an invasive management strategy.This trial was registered at ClinicalTrials.gov (Identifier: NCT03208153).

Translated text

Key words

Elderly,Frailty,Acute myocardial infarction

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined